New York State Common Retirement Fund Reata Pharmaceuticals Inc Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$79.22 - $105.37 $237,897 - $316,426	-3,003 Reduced 20.67%	11,526 $1.18 Million
Q1 2023 May 02, 2023	SELL	$30.85 - $93.17 $163,720 - $494,453	-5,307 Reduced 26.75%	14,529 $1.32 Million
Q4 2022 Jan 30, 2023	SELL	$22.15 - $42.11 $199 - $378	-9 Reduced 0.05%	19,836 $754,000
Q3 2022 Nov 08, 2022	SELL	$19.41 - $36.49 $15,508 - $29,155	-799 Reduced 3.87%	19,845 $499,000
Q2 2022 Aug 04, 2022	BUY	$20.71 - $36.5 $16,692 - $29,419	806 Added 4.06%	20,644 $627,000
Q1 2022 May 05, 2022	SELL	$24.12 - $39.6 $144 - $237	-6 Reduced 0.03%	19,838 $650,000
Q4 2021 Feb 02, 2022	SELL	$25.61 - $110.96 $1,101 - $4,771	-43 Reduced 0.22%	19,844 $523,000
Q3 2021 Nov 02, 2021	SELL	$100.0 - $143.02 $381,300 - $545,335	-3,813 Reduced 16.09%	19,887 $2 Million
Q2 2021 Aug 02, 2021	SELL	$78.27 - $151.29 $526,444 - $1.02 Million	-6,726 Reduced 22.11%	23,700 $3.35 Million
Q1 2021 May 11, 2021	SELL	$94.25 - $132.81 $235,625 - $332,025	-2,500 Reduced 7.59%	30,426 $3.03 Million
Q4 2020 Feb 08, 2021	SELL	$102.03 - $184.62 $255,075 - $461,550	-2,500 Reduced 7.06%	32,926 $4.07 Million
Q3 2020 Nov 05, 2020	BUY	$93.53 - $163.34 $84,177 - $147,006	900 Added 2.61%	35,426 $3.45 Million
Q2 2020 Aug 07, 2020	BUY	$126.3 - $176.56 $1.52 Million - $2.12 Million	12,019 Added 53.4%	34,526 $5.39 Million
Q1 2020 May 06, 2020	SELL	$124.16 - $247.74 $208,712 - $416,450	-1,681 Reduced 6.95%	22,507 $3.25 Million
Q4 2019 Feb 05, 2020	SELL	$74.57 - $217.92 $37,285 - $108,960	-500 Reduced 2.03%	24,188 $4.95 Million
Q3 2019 Nov 07, 2019	BUY	$71.26 - $95.75 $57,506 - $77,270	807 Added 3.38%	24,688 $1.98 Million
Q2 2019 Aug 09, 2019	BUY	$77.72 - $94.35 $188,237 - $228,515	2,422 Added 11.29%	23,881 $2.25 Million
Q1 2019 May 08, 2019	BUY	$51.9 - $101.79 $157,412 - $308,729	3,033 Added 16.46%	21,459 $1.83 Million
Q4 2018 Feb 08, 2019	BUY	$48.76 - $76.44 $34,132 - $53,508	700 Added 3.95%	18,426 $1.03 Million
Q2 2018 Aug 10, 2018	BUY	$19.94 - $40.96 $107,676 - $221,184	5,400 Added 43.81%	17,726 $620,000
Q4 2017 Feb 13, 2018	BUY	$22.39 - $33.27 $40,302 - $59,886	1,800 Added 17.1%	12,326 $349,000
Q2 2017 Aug 11, 2017	BUY	N/A	10,526	10,526 $333,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account